UA118435C2 - METHOD OF COMPREHENSIVE TREATMENT OF LIVER CYROSIS BY FETAL STEM CELL MEGADOSES IN COMBINATION WITH FETAL TISSUE AND PLACENTA EXTRACTS - Google Patents

METHOD OF COMPREHENSIVE TREATMENT OF LIVER CYROSIS BY FETAL STEM CELL MEGADOSES IN COMBINATION WITH FETAL TISSUE AND PLACENTA EXTRACTS

Info

Publication number
UA118435C2
UA118435C2 UAA201805224A UAA201805224A UA118435C2 UA 118435 C2 UA118435 C2 UA 118435C2 UA A201805224 A UAA201805224 A UA A201805224A UA A201805224 A UAA201805224 A UA A201805224A UA 118435 C2 UA118435 C2 UA 118435C2
Authority
UA
Ukraine
Prior art keywords
fetal
megadoses
combination
stem cell
liver
Prior art date
Application number
UAA201805224A
Other languages
Ukrainian (uk)
Inventor
Віктор Володимирович Радченко
Володимир Вікторович Радченко
Валерія Вікторівна Сірман
Анатолій Костянтинович Маслюков
Original Assignee
Сірман Віктор Мірчович
Віктор Володимирович Радченко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сірман Віктор Мірчович, Віктор Володимирович Радченко filed Critical Сірман Віктор Мірчович
Priority to UAA201805224A priority Critical patent/UA118435C2/en
Publication of UA118435C2 publication Critical patent/UA118435C2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Винахід стосується способу комплексного лікування цирозу печінки мегадозами фетальних стовбурових клітин у поєднанні з екстрактами фетальних тканин та плаценти, передбачає приготування препаратів у вигляді суспензій, отриманих з фетусу та плаценти після виконання медичного аборту в період 8-12 тижнів гестації, які містять стовбурові клітини фетальної печінки, фетального головного мозку та фетального серця та екстракті, виготовлених з плаценти і фетального тимусу, та введення вказаних суспензій та екстрактів на фоні стандартної терапії.The invention relates to a method of complex treatment of liver cirrhosis with fetal stem cell megadoses in combination with fetal tissue and placenta extracts; , fetal brain and fetal heart and extract made from placenta and fetal thymus, and the introduction of these suspensions and extracts on the background of standard therapy y.

UAA201805224A 2018-05-11 2018-05-11 METHOD OF COMPREHENSIVE TREATMENT OF LIVER CYROSIS BY FETAL STEM CELL MEGADOSES IN COMBINATION WITH FETAL TISSUE AND PLACENTA EXTRACTS UA118435C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201805224A UA118435C2 (en) 2018-05-11 2018-05-11 METHOD OF COMPREHENSIVE TREATMENT OF LIVER CYROSIS BY FETAL STEM CELL MEGADOSES IN COMBINATION WITH FETAL TISSUE AND PLACENTA EXTRACTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201805224A UA118435C2 (en) 2018-05-11 2018-05-11 METHOD OF COMPREHENSIVE TREATMENT OF LIVER CYROSIS BY FETAL STEM CELL MEGADOSES IN COMBINATION WITH FETAL TISSUE AND PLACENTA EXTRACTS

Publications (1)

Publication Number Publication Date
UA118435C2 true UA118435C2 (en) 2019-01-10

Family

ID=65577236

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201805224A UA118435C2 (en) 2018-05-11 2018-05-11 METHOD OF COMPREHENSIVE TREATMENT OF LIVER CYROSIS BY FETAL STEM CELL MEGADOSES IN COMBINATION WITH FETAL TISSUE AND PLACENTA EXTRACTS

Country Status (1)

Country Link
UA (1) UA118435C2 (en)

Similar Documents

Publication Publication Date Title
MX2018010508A (en) Improved preparations of adult liver progenitor cells.
WO2016061464A8 (en) In vivo model of human small intestine using pluripotent stem cells and methods of making and using same
PH12017502283A1 (en) A method of treatment
MX2023003296A (en) Generating atrial and ventricular cardiomyocyte lineages from human pluripotent stem cells.
MX2019003547A (en) Uses of oxygenated cholesterol sulfates (ocs).
MX2020000713A (en) Apheresis methods and uses.
PH12017500032A1 (en) Improved a� protofibril binding antibodies
MX2021000295A (en) Dimeric immuno-modulatory compounds against cereblon-based mechanisms.
BR112017014361A2 (en) methods for perfecting cell therapy
WO2014183033A3 (en) G-csf for use in treating or preventing a disease associated with aging in a patient, for administration with a stem-cell containing composition and/or an electromagnetic signal
AU2018253575A1 (en) Natural killer cells from placenta
MX2018011875A (en) Enhanced direct cardiac reprogramming.
MX2022006073A (en) Methods of use of anti-trem2 antibodies.
PH12021550035A1 (en) Combination therapy
RU2018107704A (en) MEDICINE CONTAINING ATTRACTANT OF FAT STEM CELLS TO IMPROVE THE FRUIT OR AGING OF THE SKIN CAUSED BY THE FORMATION OF DERMAL CAVITIES
AU2012388759A8 (en) Methods and compositions for hypotensive resuscitation
MX2019000677A (en) B-cell-mimetic cells.
UA118435C2 (en) METHOD OF COMPREHENSIVE TREATMENT OF LIVER CYROSIS BY FETAL STEM CELL MEGADOSES IN COMBINATION WITH FETAL TISSUE AND PLACENTA EXTRACTS
TW201612313A (en) Uses of ligustilide
EA201792603A1 (en) ANGIOGENESIS USING STIMULATED PLACENTAL STEM CELLS
ZA201907623B (en) T cells with reduced surface fucosylation and methods of making and using the same
BR112017012911A2 (en) method for treating heart failure
MX2019014988A (en) Method for reducing or preventing cardiovascular events in patients with type ii diabetes mellitus.
SG11202012127YA (en) Acellular organs, and methods of producing the same
UA126723U (en) METHOD OF COMPLEX THERAPY OF AUTOMATIC SPECTRUM DISORDERS OF MEGADOSES OF FETAL STEEL CELLS AND PLACENTARY ORIGINATING EXTRACTS